Navigation Links
ZYBAN, The smoking cessation drug marked for its adverse reactions

GlaxoSmithKline's smoking cessation drug Zyban, which is being taken by over 5 million people world wide, is held responsilble for a raise in the suspected adverse reactions due to drug intake in UK.

Pharmacovigilance statistics of MCA has shown a raise of about 37% more adverse reactions so called "yellow cards" during the period of January to April 2001 compared to that of last years. MCA spokeswoman explained that the main factor responsible for such an increase in the "yellow cards" is the smoking cessation aid Zyban. However, from January to April 2001 Zyban "accounted for 32% of all yellow cards" she added.

Over 5000 adverse reactions including 40 deaths relating to Zyban has been reported.

As a result of this, the UK Committee on Safety of Medicines issued a statement to doctors and patients recommending change in the starting doses of Zyban and to use the drug only on compelling reasons for the patients at risk of seizures.

GSK spokesmam in response to this commented that Zyban is a prescription-only medicine that must be taken appropriately and not by patients with a history of seizures. He also added that the rate of seizures seen was consistent with the clinical trials experience.
'"/>




Page: 1

Related medicine news :

1. Vaccine to quit smoking?
2. A boost to quit smoking
3. Quitting smoking stops lung decline
4. Passive smoking affects respiratory system
5. Stop smoking and reduce weight
6. Teens listen to parents about smoking
7. Teen smoking declines
8. Cancer patients pursue smoking inspite of risks
9. A new herbal therapy to quit smoking
10. Watching television linked to smoking
11. Quit smoking after cancer diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving compilation of ... value to God. “Letters From Home” is the creation of published author, John Allred, ... Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on four continents. ...
(Date:9/22/2017)... ... September 22, 2017 , ... Egg ... life. Although frozen embryos have a slight statistical advantage for live births, frozen ... a wonderful opportunity for women undergoing medical treatment or who are concerned about ...
(Date:9/21/2017)... ... September 21, 2017 , ... With ProSlideshow Portrait from ... easy to do. Users can select from up to two layers of subject matter ... of a mouse all within Final Cut Pro X. , With ProSlideshow ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/processcapabilityindices      ... things wrong, run afoul of The Quality System Regulation (§820.250), and Devicemakers find ...
(Date:9/21/2017)... CA (PRWEB) , ... September 21, 2017 , ... ... lunch and learn with Infinity Behavioral Health Services for professionals in the addiction ... a Commercial Payer Audit . , Insurance companies and state and federal ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... -- Just 18 months after its February 2016 launch, market ... appointment of three new senior people to its rapidly ... and James Wright bring decades of ... Tammy Wynne joins as Director, Value ... has over ten years, experience in global market access ...
(Date:9/1/2017)... , Sept. 1, 2017 Michael ... Solutions, Inc , highlights opportunities for growth in his ... report that Marlin Equity is seeking a buyer for ... annual award-winning 22-year-old healthcare solutions Value Added Reseller and ... "As the healthcare market ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the latest ... Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... include new preclinical and clinical data on Bayer,s marketed portfolio ... pipeline projects. "We ... minds in cancer research at ESMO," said Carsten Brunn ...
Breaking Medicine Technology: